ClinicalTrials.gg
RecruitingNCT06368674Updated Apr 11, 2025

Bridging the Gap: Creating a Continuum of Care

An interventional study of Intervention group Case Manager (CM) and Control Group in Frailty, Dependence and Integrated Care, sponsored by Göteborg University. Recruiting at 1 site in Sweden. Open to participants aged 75 Years and older. Per ClinicalTrials.gov, last updated 2025-04-11.

Sponsored by Göteborg University · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Started Jun 2024; still recruiting 2 years 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
150
Allocation
Non-randomized
Ages
75 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 32 studies in Frailty with a site in Sweden — 11 open to participants now, 13 under way, none of them phase 3. Frailty · Sweden.

Planned enrollment
11th of 14
150 · median 216
Started
2024
with 4 others
No phase
14 of 32
7 open now
Primary completion
2026-12
later than 5 of 12 live
Registered
25th of 32
by date
Lead sponsor
3 of 32
Göteborg University

Among the 32 studies in Frailty with a site in Sweden, this one is the 11th largest by planned enrollment of the 14 interventional ones that give a count, is one of 5 that started in 2024, is one of 14 with no phase, reaches primary completion later than 5 of the 12 other live ones, and was the 25th registered.

Frailty

1,291 studies on the registry are indexed under Frailty; 454 are open to participants now.

Browse Frailty studies →

Open to participants now

11 of the 32 studies in Frailty with a site in Sweden are open now. Recruiting first, the newest first:

5 more — sign in →

All 11 open studies →

A study can be open while its sites in Sweden have not opened yet or have stopped. Only those recruiting at a site in Sweden →

Who these studies take

Of the 299 Frailty studies recruiting now, 235 (79%) set no upper age limit and 10 (3%) stop at 75 or younger; 7 take children under 18; 66 take healthy volunteers.

This study: 75 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 32 studies in Frailty with a site in Sweden, or all of them as a file.
02

Study summary

Coordination and integration between care settings is essential for the quality of care of frail older patients. An active follow-up by a case manager (CM) after discharge form an acute geriatric hospital ward has the potential to bridge the gap between hospital, primary and municipality care for frail older people. This study evaluates the effects of an active follow-up by a CM in primary care after discharge from a geriatric ward, with the following research questions: Can an active follow-up by CM for frail older people discharged from an acute geriatric ward, compared to those not receiving active follow up, Maintain/increase independence in activities of daily living, self-rated health and life satisfaction? Increase satisfaction with health care? Reduce health care consumption/be cost-effective? How feasible is the intervention and the study design from the perspective of the caregivers and the older person? This is a clinical controlled study with a process evaluation. Inclusion criteria are 75 years or older, frail and admitted to a geriatric ward.

This study is relevant since today's highly specialized acute care is poorly adapted to the comprehensive needs of frail older people, and exposes them to avoidable risks such as loss of functional capacities causing unnecessary care needs and decreased wellbeing. Active follow-up by a CM after discharge may be an important way to integrate the care for frail older people, after receiving in-hospital geriatric care. This can improve the quality of care for this vulnerable group, and direct the right health care actions towards those in most need.

The intervention is a active follow-up after discharge by a CM (nurse) in primary care. CM will secure that discharge and care plans are executed and to address new needs. If there are unmet needs, the CM will ensure that adequate actions are performed to meet the needs. The intervention group consists of participants discharged to a primary health care centre with a CM, who actively follows-up after discharge. The control group consists of participants discharged to a primary health care centre without CM, and thereby no active follow-up after discharge. All participants will be followed-up by the research team during one year, concerning dependence in activities of daily living, self-rated health, health care consumption and satisfaction with care.

03

Conditions studied

  • Frailty
  • Dependence
  • Integrated Care

Browse trials for

Keywords

  • Person-centred care
04

Who can participate

Ages eligible
75 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

75 years or older, screened as frail, admitted to an acute geriatric ward working according to CGA at the Sahlgrenska or Mölndal hospital. Both hospitals are part of Sahlgrenska University hospital, with the same catchment area, including Gothenburg with surrounding municipalities. People in the region can seek care at both hospitals. The orthopaedic clinic is situated at Mölndal hospital, resulting in most patients with fractures being admitted to this hospital, irrespective of in which municipality they are living. Cognitive impairment is not an exclusion criterion. For people who cannot give due to cognitive impairment, next of kin will be asked to assist with the consent.

Exclusion criteria

Exclusion Criteria:

Less that 75 years old, Not residing in a permanent residence.

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
150 participants (estimated)

Study arms

  • Experimental
    Intervention group Case Manager (CM)

    The intervention group will receive extra follow-up by a CM after discharge.

    Other: Intervention group Case Manager (CM)

  • Other
    Control group

    The control group will receive usual follow-up after discharge, i.e. no active follow-up

    Other: Control Group

Interventions

  • OtherIntervention group Case Manager (CM)

    The CM will be informed about the discharge plan from the nurse at the geriatric ward, as will the municipality for those with need of home help care. An outline of the intervention has been created with managers from primary care and rehabilitation within primary care and municipality care. Core components in the intervention will be active follow-up of the discharge, rehabilitation and care plans. If there are plans that have not been executed or unmet needs, the CM will take adequate contacts to ensure that actions are made to meet the needs. These contacts can be, e.g. the GP for medical needs, the rehabilitation unit in primary or municipality care for unmet rehabilitation needs, and the home help service for unmet care needs. The CM will have a network of contact persons in hospital, primary and community care, as well as in rehabilitation in primary and community care, in order to facilitate for prompt actions to meet the needs.

  • OtherControl Group

    The participants in the control group with a planned follow-up by a primary health care centre within the catchment area of the Sahlgrenska University Hospital that does not have CMs designated for active follow up of discharged frail older people. Thus, the participants in the control group will not actively be followed-up after discharge.

06

What researchers measure

Primary outcomes

  1. Dependency in Activities of Daily Living (ADL)

    The primary outcome, dependence in activities of daily living, is measured using the ADL-staircase assessment. It measures dependence in 9 activities: cleaning, shopping, transportation, cooking, bathing, dressing, going to the toilet, transferring, and feeding. Dependence is defined as a state in which another person is involved in the activity by giving personal or directive assistance. The sum of dependence in the nine activities of daily living will be calculated, range 0-9, with a clinical significant change of ≥1 unit between baseline and follow up.

    Time frame: Baseline to 12 months

Secondary outcomes

  1. Self-rated health

    Measured by the question: "In general, you would say your health is", with the response alternatives: excellent, very good, good, fair, and poor. Clinically significant difference is ≥1 step in the response alternatives between baseline and follow up.

    Time frame: Baseline to 12 months

  2. Life satisfaction

    Measured using the Fugl-Meyer-Lisat-11questionnaire, which includes 11 items concerning satisfaction with: life as a whole, work, financial situation, leisure, friends and acquaintance, sexual life, functional capacity, family life, partner relationship, physical health, and psychological health. Response alternatives are: very dissatisfied, dissatisfied, rather dissatisfied, rather satisfied, satisfied, and very satisfied. The sum of items for which the respondent reports being satisfied will be calculated, range 0-11, with a clinically significant change of ≥1 between baseline and follow up.

    Time frame: Baseline to 12 months

  3. Satisfaction with quality of care

    Measured by the participants' agreement with the following statements: "I feel that the care given during the hospital stay meets my needs"; "I am satisfied with the hospital care"; "I feel that the care planning meeting before discharge was valuable"; "I was able to take part in the discussions of my needs in the care planning meeting"; "I feel that the actions planned equal my needs", "I feel that the actions delivered equal my needs"; "I feel that the follow-up after discharge by primary care/rehabilitation/ home help care meet my needs"; and "I feel that it is valuable to have a designated case manager in the primary care". The response alternatives are: agree completely, agree partly, neither agree nor disagree, disagree, and disagree completely. An answer of agree completely or agree partly will be considered as being satisfied.

    Time frame: Baseline to 12 months

  4. Health economics

    Health and social care consumption for 1 year following study enrolment. Health care consumption will be retrieved from the regional care databases, including in-hospital and outpatient care, visits to primary healthcare (physicians, physiotherapists, occupational therapists, nurses, and assistant nurses), and home visits by primary healthcare professionals. The number of readmissions, number of in-hospital days, time to first readmission, and number of outpatient visits will be calculated and compared between intervention and control group.

    Time frame: 12 months

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2024 (actual). Primary completion is estimated for Dec 2026, 30 months after the start.

Of 514 non-industry interventional studies with no phase under Frailty, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 39. This study's planned 30 months is above that.

Counting every sponsor, half of 519 studies reached it within 22 months; a quarter within 10 and three quarters within 39.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 11, 2024
First posted
Apr 16, 2024
StartActual
Jun 6, 2024
Primary completionEst.
Dec 31, 2026
CompletionEst.
Feb 1, 2027
Last update
Apr 11, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 11, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06368674
Collaborators
Vastra Gotaland Region, Narhalsan Reasearch and Development primary care Region Vastra Gotaland, Sahlgrenska University Hospital, Forte
Responsible party
Sponsor
First posted
Apr 16, 2024
Start date
Jun 6, 2024
Primary completion
Dec 31, 2026 (estimated)
Completion
Feb 1, 2027 (estimated)
Last update
Apr 11, 2025

Study contacts

Theresa Westgård, PhD, Associate Professor
Contact
Theresa.westgard@neuro.gu.se
18628820334
Isabelle Andersson Hammar, PhD, Associate Professor
Contact
Isabelle.a-h@neuro.gu.se
+46766185719

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion